NETWise

NETWise Episode 4: Nuclear Medicine for NETs: What is PRRT?


Listen Later

Treating NETs with Nuclear Medicine

This episode of NETRF’s NETWise podcast discusses Peptide Receptor Radionuclide Therapy (PRRT) a targeted form of radiotherapy approved in the U.S. in 2018. Listen in as NET experts like Josh Mailman, Drs. George Fisher, Thor Halfdanarson, Ed Wolin, Richard Baum, and others explain what it is, how it works, and who is most likely to benefit from PRRT. This therapy relies on a tumor’s expression of somatostatin receptors. We explain what they are and how to know if you have them.

Then, we’ll take an objective look at the success rates for this therapy. What does research, like the NETTER-1 study, tell us about outcomes for this form of treatment? To give you information about both the pros and cons of PRRT, we will also discuss the potential side effects, from mild to serious. To give you a sense of what it is like to undergo PRRT, we’ll talk with multiple patients about their experience with the procedure itself, as well as the radiation safety precautions patients should take immediately following treatment. Finally, we look to the future asking Drs. Rod Hicks and Tom Hope to explain some of the new therapeutic directions PRRT is taking.

Use our episode infographics to get a visual picture of some of the things we have discussed.

PRRT for NETs. This handout explains how radioactive drugs are able to target NET cells with radioactivity using PRRT.

Download PDF

What is PRRT? A quick guide to answer your most basic questions about the pros and cons of PRRT.  What are the benefits of PRRT? What are the potential side effects of PRRT?  Who can be treated with PRRT? 

Download PDF
Download a transcript of this episode
Mentioned in this Episode:

Nuclear Medicine Treatments

Gallium-68 Dotatate PET/CT Scan

Search for PRRT treatment Centers Near You

What’s Next in PRRT Treatment

VIDEO: How PRRT Works and Who Benefits – Dr. Blase Polite, University of Chicago

VIDEO: What to Expect During PRRT Treatment – Karen Ohara, Rush University Medical Center

VIDEO: How PRRT Can Improve Care for NET Patients

VIDEO: Combining PRRT with Targeted Therapy

VIDEO: Tb-161: Exploring a New Radionuclide for PRRT

Additional NET Research Foundation Resources:

Request a mailed copy of our Neuroendocrine Cancer Guide

Information and Resources for the Newly Diagnosed

NETRF YouTube Channel

The post NETWise Episode 4: Nuclear Medicine for NETs: What is PRRT? appeared first on NETRF.

...more
View all episodesView all episodes
Download on the App Store

NETWiseBy Neuroendocrine Tumor Research Foundation (NETRF)

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

45 ratings


More shows like NETWise

View all
Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,566 Listeners

Up First from NPR by NPR

Up First from NPR

56,477 Listeners

The Uromigos by The Uromigos

The Uromigos

59 Listeners

The Rest Is History by Goalhanger

The Rest Is History

15,423 Listeners

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts by Neuroendocrine Cancer Foundation

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

2 Listeners

The Headlines by The New York Times

The Headlines

621 Listeners

NETCast by Podcasting4Associations

NETCast

2 Listeners